
Raffaele Colombo/LinkedIn
May 28, 2025, 07:38
Raffaele Colombo: Njardarson’s Group’s Top 200 Brand Drugs by Sales
Raffaele Colombo, Associate Director, Medicinal Chemistry at Zymeworks, posted on X:
“Every year, the Njardarson’s group (University of Arizona) compiles the top 200 brand drugs by sales. The 2024 list is now posted!
For ADCs, 2023 vs 2024 ranks:
Enhertu 65 to 51
Padcev >200 to 73
Kadcyla 67 to 94
Trodelvy 162 to146
Polivy 169 to 159Total ~$13 billions!”
More posts featuring Raffaele Colombo.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 29, 2025, 14:15
May 29, 2025, 13:35
May 29, 2025, 13:11